| 80.77 Delayed Data As of Feb 22 |  0.00 / 0.00%Today’s Change | 52.83 Today|||52-Week Range 80.86 | +5.71% Year-to-Date |
| Previous close | 80.77 |
| Today’s open | 79.77 |
| Day’s range | 79.77 - 80.86 |
| Volume | 7,955,621 |
| Average volume (3 months) | 13,269,550 |
| Market cap | $207.3B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +7.57% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +5.79% |
| P/E ratio | 64.6 |
| Price/Sales | 4.84 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | 0.00 | 0.00% |
| PFEPfizer | 0.00 | 0.00% |
| ABBVAbbVie | +1.27 | +1.61% |
| ABTAbbott Laboratories | +0.99 | +1.32% |
| Next reporting date | April 30, 2019 |
| EPS forecast (this quarter) | $1.08 |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $6.0B |
| Net profit margin | 14.58% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
